Article Link: Bristol-Myers Squibb’s Opdivo (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treate...

Article Link: BioCryst’s Rapivab (peramivir injection) Receives FDA Approval for a Pediatric Indication Source: FDA N...

Article Link: Optinose Announces FDA Approval of Xhance (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps �...

Article Link: FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD Source: ...

Article Link: FDA Approves Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women &...

Article Link: FDA Approves New Indication for Ipsen’s Somatuline Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome �...

Article Link: Neos Therapeutics Receives U.S. FDA Approval of Adzenys ER (amphetamine) Extended-Release Oral Suspension for ADHD &...

Article Link: FDA Approves New indication for Briviact (brivaracetam) as Monotherapy Treatment of Partial-Onset Seizures in Adults ...

Article Link: FDA Approves Mvasi (bevacizumab-awwb), a Biosimilar to Avastin Source: FDA New Drug Approvals

Article Link: FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma Source: FDA New Drug Approvals